Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Receives Average Recommendation of “Moderate Buy” from Brokerages

Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) have been assigned a consensus recommendation of “Moderate Buy” from the seven research firms that are covering the firm, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average 1 year target price among brokerages that have issued a report on the stock in the last year is $94.75.

Several brokerages have recently weighed in on ACHC. Barclays began coverage on shares of Acadia Healthcare in a research note on Wednesday, March 6th. They set an “overweight” rating and a $100.00 target price for the company. Cantor Fitzgerald reiterated a “neutral” rating and set a $90.00 target price on shares of Acadia Healthcare in a research note on Tuesday, March 5th. Mizuho increased their target price on shares of Acadia Healthcare from $77.00 to $84.00 and gave the stock a “neutral” rating in a research note on Wednesday, March 6th. TD Cowen increased their target price on shares of Acadia Healthcare from $86.00 to $101.00 and gave the stock an “outperform” rating in a research note on Friday, March 1st. Finally, TheStreet upgraded shares of Acadia Healthcare from a “c” rating to a “b-” rating in a research note on Monday, March 4th.

Insider Buying and Selling at Acadia Healthcare

In other Acadia Healthcare news, Director Wade D. Miquelon sold 2,203 shares of the stock in a transaction dated Tuesday, March 5th. The shares were sold at an average price of $85.39, for a total value of $188,114.17. Following the completion of the transaction, the director now directly owns 46,074 shares of the company’s stock, valued at $3,934,258.86. The sale was disclosed in a filing with the SEC, which is available at this link. 2.80% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of ACHC. Campbell & CO Investment Adviser LLC increased its stake in shares of Acadia Healthcare by 177.4% during the 3rd quarter. Campbell & CO Investment Adviser LLC now owns 7,357 shares of the company’s stock worth $517,000 after purchasing an additional 4,705 shares in the last quarter. Vaughan Nelson Investment Management L.P. purchased a new position in shares of Acadia Healthcare during the 4th quarter worth approximately $24,157,000. Louisiana State Employees Retirement System purchased a new position in shares of Acadia Healthcare during the 4th quarter worth approximately $2,014,000. Phocas Financial Corp. purchased a new position in shares of Acadia Healthcare during the 4th quarter worth approximately $6,887,000. Finally, Raymond James Financial Services Advisors Inc. increased its stake in shares of Acadia Healthcare by 109.3% during the 4th quarter. Raymond James Financial Services Advisors Inc. now owns 44,300 shares of the company’s stock worth $3,445,000 after purchasing an additional 23,138 shares in the last quarter.

Acadia Healthcare Stock Down 0.2 %

Acadia Healthcare stock opened at $70.16 on Friday. Acadia Healthcare has a twelve month low of $66.49 and a twelve month high of $87.77. The stock’s fifty day simple moving average is $79.18 and its 200-day simple moving average is $77.62. The company has a current ratio of 0.67, a quick ratio of 0.67 and a debt-to-equity ratio of 0.48. The firm has a market capitalization of $6.48 billion, a P/E ratio of -280.63, a P/E/G ratio of 2.07 and a beta of 1.31.

Acadia Healthcare (NASDAQ:ACHC) last posted its earnings results on Wednesday, February 28th. The company reported $0.85 EPS for the quarter, beating the consensus estimate of $0.80 by $0.05. Acadia Healthcare had a positive return on equity of 11.21% and a negative net margin of 0.74%. The firm had revenue of $742.80 million for the quarter, compared to analyst estimates of $727.60 million. During the same quarter in the prior year, the company posted $0.70 earnings per share. Acadia Healthcare’s revenue for the quarter was up 10.0% compared to the same quarter last year. As a group, equities analysts expect that Acadia Healthcare will post 3.57 earnings per share for the current fiscal year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.